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The first case of HIV in Nigeria was reported in 
1986 in a sexually-active 13 years old girl, and soon 
afterwards, HIV infection was identified among 
commercial sex workers in Lagos and Enugu. Cases 
of HIV infection were occasionally reported from 
various parts of the country and have been growing 
steadily (1). Now, Nigeria has the largest HIV/AIDS 
epidemic in sub-Sahara Africa (2). A syphilis-preva-
lence rate of 4.1% and 4% was reported among 
commercial sex workers in Ibadan and Lagos 
respectively (3,4). A syphilis-seroprevalence rate of 
0.125%, 1.7%, and 2.97% was also reported among 
pregnant women in Enugu, Ilorin, and Oshogbo 
respectively (5-7).
Insufficient information on the prevalence of 
HIV-syphilis co-infection in Nigeria is available. 
Nnoruka and Ezeoke attempted to fill this gap by 
reporting a 2.1% prevalence rate of HIV-syphilis 
co-infection in a hospital setting in Enugu state of 
Nigeria (8). Their study did not look at the influ-
ence of such a concurrent HIV-syphilis infection 
on the immune system, which is critical in the 
proper management of this group of patients. As 
far as we know, no study in northern Nigeria (HIV/
AIDS hotspot) has looked at this phenomenon. To 
begin to address this public-health problem in this 
very vast country (over 148 million inhabitants in 
an area of 923,768 sq km), we conducted a study 
on the prevalence of HIV-syphilis co-infection and 
the possible effect of such co-infection on the CD4+ 
lymphocyte levels among HIV-infected individuals 
in North Central Nigeria. 
Four hundred plasma samples were randomly se-
lected from western blot-confirmed HIV 1-positive 
samples stored at -24 ºC in the Virology Laboratory 
of Innovative Biotech (IBL), Keffi, Nasarawa state, 
Nigeria. These samples were collected during June 
2005–December 2007 from clients who accessed 
IBL services for voluntary HIV counselling and test-
ing or for other health needs. Before each client was 
bled, informed consent was obtained according to 
the IBL and international regulations. These sam-
ples were labelled with serialized IBL code numbers 
that could not be linked to individuals. As patients 
were bled, a superior fluorescence-activated cell-
sorter system (Becton Dickenson FACSCount, Can-
ada) was used for enumerating the absolute values 
for CD4+ cells for each sample according to the 
instructions of the manufacturer. The CD4+/CD8+ 
ratios were also enumerated using the FACSCount 
method in a closed tube format. 
Anti-Treponema palladium (the spirochete that 
causes syphilis) antibodies (IgG and IgM) were 
detected in plasma using the ShantestTM syphilis 
test-kit [(Shantha Biotechnics Ltd., Hyderabad, In-
dia; Lot number: 5151101; sensitivity 99.7% (98.6-
100%); specificity 99.6% (98.5-100%)] which use 
a double antigen combination of a recombinant 
syphilis antigen-coated particle and syphilis anti-
gen immobilized on membrane to detect T. pal-
ladium antibodies (IgG and IgM) qualitatively and 
selectively in plasma. The test was carried out and 
interpreted according to the instructions of the 
manufacturer.
Demographic data (age and gender) of the par-
ticipants were retrieved from the coded electronic 
registration records of clients maintained at the 
IBL. The seroprevalence of HIV and syphilis and 
median were obtained after recording data in a Mi-
crosoft Excel worksheet on a Windows 98 platform. 
The IBL research committee and the ethical com-
mittee of the Nasarawa State University approved 
the study.
Of the 400 samples tested, 263 were from females 
and 137 from males. Thirteen individuals were 
positive for both HIV and syphilis. The prevalence 
of HIV-syphilis co-infection was 3.3%. Of the 13 in-
dividuals co-exposed to HIV and syphilis, five were 
female while eight were male. More males were 
HIV-syphilis  co-exposed  but  this  was  not  signifi-
cant. The age range of the study patients was 15-67 
years (mean 32 years). The mean age of HIV-syphi-Forbi JC et al. Seroprevalence of syphilis in Nigeria
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lis co-infected females was 30.4 years against 46.3 
years for males. There was no age preference for 
HIV-syphilis co-infection. The prevalence of HIV-
syphilis among females was 1.9% (5/263) and 5.8% 
(8/137) among males. The ratio between males and 
females with HIV-syphilis co-infection was approxi-
mately 1.6:1. The median CD4+ value of HIV-syphi-
lis co-infected individual was 27 cells/µL (range 1-
453 cells/µL) while that for those with only HIV 
infection was 169 cells/µL (range 1-980 cells/µL). 
The CD8+ values in HIV-syphilis co-infection were 
usually over three times greater than CD4+ values. 
This was, however, not too different from an obser-
vation in HIV mono-infected individuals. 
Since HIV and syphilis are both sexually transmissi-
ble infections, their association in the same indivi- 
dual is not unusual. HIV infection may alter prima-
ry manifestations of syphilis, leading to an atypi-
cal presentation and/or multiple ulcers that may be 
mistaken for genital herpes. Lesions fitting the clas-
sic descriptions of painless, solitary ulcers with in-
durations only occur in 31% of patients with syphi-
lis (9). As many as one in three HIV-infected people 
continue to have unprotected sex after knowing 
that they are HIV-positive, and unprotected sex of-
ten occurs with unknown sero-status or HIV-nega-
tive individual (10). The samples used in this study 
were collected from Nasarawa state and Abuja. This 
axis is a known HIV/AIDS hotspot (1).
The present study estimated the prevalence of 
HIV-syphilis co-infection rate of 3.3% among HIV-
infected individuals. This is in agreement with 
Nnoruka and Ezeoke (8) who reported 2.1% preva-
lence rate of HIV-syphilis co-infection in Enugu 
state of Nigeria. Results of several epidemiological 
studies showed that the prevalence of syphilis in 
Nigeria ranged from 0.125% to 4.1% among preg-
nant women and commercial sex workers (3-7). It 
is likely that the prevalence of syphilis in Nigeria 
could be in the same range regardless of occupation 
in different segments of the Nigerian population. 
The rate of syphilis infection in Nigeria is lower 
compared to other countries in the West-African 
subregion. For example, the syphilis-seroprevalence 
rate of 11%, 20%, and 23.8% has been reported 
in Ghana, Sierra Leone, and Senegal respectively 
(11-13). The unofficially-unrestricted sales of drug 
in buses, streets, and markets in Nigeria result in 
an extensive use of antibiotics, especially ampicil-
lins which can stop syphilis. This could result in 
a low and inefficient transmission of T. palladium, 
leading to the eventual decrease in the number of 
seropositive individuals over time. The low preva-
lence of syphilis among HIV-infected individuals in 
the present study and other studies from Nigeria 
suggests that elimination of syphilis is possible in 
Nigeria if preventive and control measures are put 
in place.
The ratio between males and females with HIV-
syphilis co-infection was approximately 1.6:1. 
Therefore, HIV-infected men are 1.6 times more 
likely to be syphilis-positive than HIV-infected 
women. This is in line with the Rio de Janeiro study 
where a larger number of men than women were 
co-infected with HIV and syphilis (14). We did not 
find an association between the prevalence of HIV-
syphilis co-infection and age. This is perhaps due to 
the increasing and widespread distribution of HIV 
infection in all age-categories in Nigeria.
In this study, the median CD4+ counts was lower 
among individuals co-exposed to HIV/syphilis 
(median CD4+=27 cells/µL) when compared with 
individuals having HIV mono-infection (median 
CD4+=169 cells/µL). Although our study is limi-
ted by the fact that we cannot clearly state if the 
syphilis infection we detected was active or prior, 
we think that our observation perhaps corrobo-
rates the observation of Sadiq et al. and Palacios et 
al. who found a drop in the CD4+ count among 
individuals with HIV/syphilis co-infection in the 
United Kingdom and Spain respectively (15,16). 
Furthermore, Kofoed et al., in Copenhagen, Den-
mark, demonstrated that treatment of syphilis was 
associated with an increase in the CD4+ cell count 
(17). The combination of HIV and syphilis is a 
dangerous one and provides further challenges to 
HIV-control programmes, particularly in countries 
in sub-Saharan Africa that have a high prevalence 
of HIV infection. 
Although the seroprevalence of syphilis among 
HIV-infected individuals is low in Nigeria, we recom- 
mend a nation-wide integration of screening 
and treatment of syphilis in the overall manage-
ment of HIV infection because of the potentially-
devastating effect of this dual infection on the im-
mune system. This has been shown to have some 
benefits in countries where the practice is adopted. 
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